Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): When and how

F1000 Medicine Reports

Volumn 2, Issue 1, 2010, Pages

  Falchetti, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOMAL LOCALIZATION; FAMILY HISTORY; FOLLOW UP; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; PRENATAL DIAGNOSIS; REVIEW;

EID: 77955972766     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M2-14     Document Type: Review

References (38)

1. Wermer P: Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954, 16:363.
2. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86:5658-71. (Pubitemid 33152604)
3. Anlauf M, Perren A, Meyer CL, Schmid S, Saremaslani P, Kruse ML, Weihe E, Komminoth P, Heitz PU, Klöppel G: Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas. Gastroenterology 2005, 128:1187-98.
4. Fendrich V, Langer P, Waldmann J, Bartsch DK, Rothmund M: Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas. Br J Surg 2007, 94:1331-41.
5. Brandi ML, Bordi C, Tonelli F, Falchetti A, Marx SJ: Multiple endocrine neoplasia type 1. In Principles of Bone Biology. Vol. 2. 3rd edition. Edited by Bilezikian JP, Raisz LG, Rodan GA. San Diego, CA, USA: Academic Press; 2008:1345-74.
6. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjöld M: Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988, 332:85-7.
7. Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E, Zimering M, Weinstein L, Mc Bride WO, Nakamura Y, Brandi ML, Norton JA, Aurbach GD, Spiegel AM, Marx SJ: Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 1989, 321:213-8. (Pubitemid 19187161)
8. Emmert-Buck MR, Lubensky IA, Dong Q, Manickam P, Guru SC, Kester MB, Olufemi SE, Agarwal S, Burns AL, Spiegel AM, Collins FS, Marx SJ, Zhuang Z, Liotta LA, Chandrasekharappa SC, Debelenko LV: Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis. Cancer Res 1997, 57:1855-8. (Pubitemid 27209710)
9. Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci U S A 1993, 90:10914-21.
10. Menin - protein results: National Center for Biotechnology Information. [http://www.ncbi.nlm.nih.gov/protein?term=menin].
11. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ: Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997, 276:404-7.
12. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G, Pugeat M, Calender A, Parente F, Quincey D, Gaudray P, De Wit MJ, Lips CJ, Höppener JW, Khodaei S, Grant AL, Weber G, Kytölä S, Teh BT, Farnebo F, Thakker RV: Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 1997, 6:1177-83.
13. Gao SB, Feng ZJ, Xu B, Wu Y, Yin P, Yang Y, Hua X, Jin GH: Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin. Oncogene 2009, 28:4095-104.
14. Verges B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C, Calender A: Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002, 87:457-65. (Pubitemid 34158204)
15. Falchetti A, Marini F, Luzi E, Giusti F, Cavalli L, Cavalli T, Brandi ML: Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. Genet Med 2009, 11:825-35.
16. Agarwal SK, Lee Burns A, Sukhodolets KE, Kennedy PA, Obungu VH, Hickman AB, Mullendore ME, Whitten I, Skarulis MC, Simonds WF, Mateo C, Crabtree JS, Scacheri PC, Ji Y, Novotny EA, Garrett-Beal L, Ward JM, Libutti SK, Richard Alexander H, Cerrato A, Parisi MJ, Santa Anna-A S, Oliver B, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ: Molecular pathology of the MEN1 gene. Ann N Y Acad Sci 2004, 1014:189-98.
17. Falchetti A, Marini F, Brandi ML: Multiple endocrine neoplasia type 1. GeneReviews section of the GeneTests website of the University of Washington, Seattle, WA, USA; 2005. [http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book= gene&part=men1#men1].
18. Lemos MC, Thakker RV: Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 2008, 29:22-32.
19. Lips CJ, Hoppener JW, Van Nesselrooij BP, Van der Luijt RB: Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines. J Internal Med 2005, 257:69-77.
20. Lairmore TC, Piersall LD, DeBenedetti MK, Dilley WG, Mutch MG, Whelan AJ, Zehnbauer B: Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 2004, 239:637-45.
21. Stratakis CA, Schussheim DH, Freedman SM, Keil MF, Pack SD, Agarwal SK, Skarulis MC, Weil RJ, Lubensky IA, Zhuang Z, Oldfield EH, Marx SJ: Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2000, 85:4776-80.
22. Ellard S, Hattersley AT, Brewer CM, Vaidya B: Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing. Clin Endocrinol (Oxf) 2005, 62:169-75. (Pubitemid 40203911)
23. Klein RD, Salih S, Bessoni J, Bale AE: Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory. Genet Med 2005, 7:131-8.
24. Odou MF, Cardot-Bauters C, Vantyghem MC, Carnaille B, Leteurtre E, Pigny P, Verier-Mine O, Desailloud R, Porchet N: Contribution of genetic analysis in screening for MEN1 among patients with sporadic disease and one or more typical manifestation. Ann Endocrinol (Paris) 2006, 67:581-7.
25. Jäger AC, Friis-Hansen L, Hansen TV, Eskildsen PC, Sølling K, Knigge U, Hansen CP, Andersen PH, Brixen K, Feldt-Rasmussen U, Kroustrup JP, Mollerup CL, Rehfeld JF, Blichert-Toft M, Nielsen FC: Characteristics of the Danish families with multiple endocrine neoplasia type 1. Mol Cell Endocrinol 2006, 249:123-32.
26. Raghavan R, Shah S, Kondkar AA, Dherai AJ, Desai D, Chauhan P, Lala M, Ashavaid TF: MEN1 935-1G>C splicing mutation in an Indian patient with multiple endocrine neoplasia type 1. Mol Diagn Ther 2007, 11:129-31.
27. Lemos MC, Harding B, Shalet SM, Thakker RV: A novel MEN1 intronic mutation associated with multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 2007, 66:709-13. (Pubitemid 46699546)
28. Drori-Herishanu L, Horvath A, Nesterova M, Patronas Y, Lodish M, Bimpaki E, Patronas N, Agarwal S, Salvatori R, Martari M, Mericq V, Stratakis CA: An intronic mutation is associated with prolactinoma in a young boy, decreased penetrance in his large family, and variable effects on MEN1 mRNA and protein. Horm Metab Res 2009, 41:630-4.
29. Tham E, Grandell U, Lindgren E, Toss G, Skogseid B, Nordenskjöld M: Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. J Clin Endocrinol Metab 2008, 92:3389-95.
30. Fukuuchi A, Nagamura Y, Yaguchi H, Ohkura N, Obara T, Tsukada T: A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1. Jpn J Clin Oncol 2006, 36:739-44.
31. Machens A, Schaaf L, Karges W, Frank-Raue K, Bartsch DK, Rothmund M, Schneyer U, Goretzki P, Raue F, Dralle H: Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers. Clin Endocrinol (Oxf) 2007, 67:613-22.
32. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gündogdu S, De Menis E, Mäkinen MJ, Launonen V, Karhu A, Aaltonen LA: Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 2006, 312:1228-30.
33. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Höfler H, Fend F, Graw J, Atkinson MJ: Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A 2006, 103:15558-63.
34. Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Mäkinen MJ, Tuppurainen K, Paschke R, Gimm O, Koch CA, Gündogdu S, Lucassen A, Tischkowitz M, Izatt L, Aylwin S, Bano G, Hodgson S, De Menis E, Launonen V, Vahteristo P, Aaltonen LA: Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab 2007, 92:3321-5.
35. Agarwal SK, Mateo CM, Marx SJ: Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab 2009, 94:1826-34.
36. Newey PJ, Jeyabalan J, Walls GV, Christie PT, Gleeson FV, Gould S, Johnson PR, Phillips RR, Ryan FJ, Shine B, Bowl MR, Thakker RV: Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab 2009, 94:3640-6.
37. Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Calender A, Proye CA; French Endocrine Tumor Study Group: Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg 2006, 30:654-62.
38. The American Society of Human Genetics Board of Directors and The American College of Medical Genetics Board of Directors: Points to Consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. J Hum Genet 1995, 57:1233-41